PLTR insider notice: 30,000-share sale via UBS; recent insider sales total 950,861 shares

Rhea-AI Filing Summary

Form 144 notice for Palantir Technologies, Inc. (PLTR) reports a proposed sale of 30,000 common shares through UBS Financial Services on 08/22/2025 with an aggregate market value of $4,659,450.00. The filing shows those shares were acquired as restricted stock units (RSUs) on 08/20/2025 from the issuer and were paid for on the acquisition date. The filer also discloses recent sales attributed to Shyam Sankar during the past three months totaling 950,861 shares for aggregate gross proceeds of $136,394,353.10. The notice includes the standard signature representation that the seller is not aware of undisclosed material adverse information.

Positive

• Proposed sale fully disclosed with broker, share count, market value, exchange, and sale date
• Acquisition details provided: the 30,000 shares were acquired as RSUs on 08/20/2025 and paid on that date

Negative

• Significant recent insider selling: 950,861 shares sold in the past three months for aggregate gross proceeds of $136,394,353.10
• Filing lacks context about reasons for recent large dispositions or whether trades were under a 10b5-1 plan

Insights

Securities Analyst

TL;DR: Insider sale activity disclosed; small proposed sale follows large recent dispositions.

The filing documents a planned sale of 30,000 common shares via UBS on 08/22/2025, acquired as RSUs two days earlier. The record also lists substantial sales by Shyam Sankar in the prior three months—950,861 shares with gross proceeds of $136,394,353.10—indicating significant recent insider liquidity. This Form 144 is procedural disclosure required under Rule 144 and confirms the mechanics of the transfer and payment. The filing does not provide any explanatory context for the timing of sales or indicate any changes to company operations.

Corporate Governance Expert

TL;DR: Compliance filing is complete on sale specifics but offers no governance or company-impact details.

The notice specifies broker, share count, market value, acquisition type (RSU), and dates, satisfying disclosure mechanics for an officer/affiliate sale. While the filing lists sizable prior dispositions by an individual, it contains no statements about motives, trading plans, or whether sales were pursuant to Rule 10b5-1. From a governance perspective, the document is informational only and does not itself signal a governance event or operational development.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc. 11 Madison Avenue 4th Floor New York NY 10010	30000	4659450.00	2274261581	08/22/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/20/2025	RSU	Issuer			30000	08/20/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Shyam Sankar 1200 17TH STREET FLOOR 15 Denver CO 80202	Common	08/20/2025	375000	56699625.00
Shyam Sankar 1200 17TH STREET FLOOR 15 Denver CO 80202	Common	06/10/2025	405000	53490942.00
Shyam Sankar 1200 17TH STREET FLOOR 15 Denver CO 80202	Common	08/20/2025	93092	14090995.86
Shyam Sankar 1200 17TH STREET FLOOR 15 Denver CO 80202	Common	08/21/2025	77769	12112790.24

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does PLTR Form 144 filed here report?

This Form 144 reports a proposed sale of 30,000 Palantir (PLTR) common shares through UBS on 08/22/2025 with aggregate market value $4,659,450.00.

How were the 30,000 PLTR shares acquired?

The filing states the shares were acquired as RSUs from the issuer on 08/20/2025 and payment was recorded on that date.

Did the filer sell other PLTR shares recently?

Yes. The filing lists sales by Shyam Sankar totaling 950,861 shares in the past three months for gross proceeds of $136,394,353.10.

Which exchange will the PLTR sale be executed on?

The proposed sale is reported to be executed on NASDAQ via UBS Financial Services.

Does the Form 144 state any undisclosed material information about Palantir?

By signing, the person represents they do not know any material adverse information that has not been publicly disclosed; the filing itself contains no additional material company information.